Fabrice Egros, Director at Syndax Pharmaceuticals Inc (SNDX), sold 20,408 shares at $24.31 ($496K) on 2021-03-01, disclosed to the SEC on 2021-03-03.
Open-market sale of $496k SNDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.31 | 74 | $2K | 0.4% |
| 2 | $24.31 | 10,167 | $247K | 49.8% |
| 3 | $24.31 | 10,167 | $247K | 49.8% |
| Total | $24.31 avg | 20,408 | $496K | 100% |
| Filing → |
| SNDX | SELL | 2021-05-20 | $476K | — | Filing → |